XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue (Tables)
 9 Months Ended
Sep. 28, 2025
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
Disaggregated revenue by primary geographical markets and major goods and service lines are as follows:
Reportable Segments
Three Months Ended
September 28, 2025September 29, 2024
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$178,087 $129,190 $307,277 $185,476 $116,849 $302,325 
Europe83,332 119,065 202,397 75,115 106,923 182,038 
Asia81,403 107,872 189,275 78,209 121,477 199,686 
$342,822 $356,127 $698,949 $338,800 $345,249 $684,049 
Major goods/service lines
Life Sciences Solutions$290,541 $— $290,541 $295,455 $— $295,455 
Software52,281 — 52,281 43,345 — 43,345 
Immunodiagnostics— 212,739 212,739 — 211,566 211,566 
Reproductive health— 143,388 143,388 — 133,683 133,683 
$342,822 $356,127 $698,949 $338,800 $345,249 $684,049 

Reportable Segments
Nine Months Ended
September 28, 2025September 29, 2024
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$559,437 $376,049 $935,486 $551,843 $352,619 $904,462 
Europe243,652 344,169 587,821 227,123 318,065 545,188 
Asia246,026 314,662 560,688 244,873 331,131 576,004 
$1,049,115 $1,034,880 $2,083,995 $1,023,839 $1,001,815 $2,025,654 
Major goods/service lines
Life Sciences Solutions$875,046 $— $875,046 $884,849 $— $884,849 
Software174,069 — 174,069 138,990 — 138,990 
Immunodiagnostics— 629,119 629,119 — 613,479 613,479 
Reproductive health— 405,761 405,761 — 388,336 388,336 
$1,049,115 $1,034,880 $2,083,995 $1,023,839 $1,001,815 $2,025,654